Related Experiment Video
Updated: Aug 18, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Factors affecting U.S. manufacturers' decisions to produce vaccines
Margaret S Coleman1, Nalinee Sangrujee, Fangjun Zhou
1U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. zby5@cdc.gov
Abstract:
Recent supply interruptions of childhood vaccines have had negative impacts on U.S. public health policies and vaccine delivery. To understand how manufacturers perceive production incentives and disincentives, the Centers for Disease Control and Prevention (CDC) met with the four pharmaceutical firms that sold vaccines through CDC-negotiated contracts during 2002 and 2003. These meetings shed light on the regulatory burden, high costs of the delay between initial investment and sales, and higher costs of new technologies versus older vaccines. All four manufacturers are investing more in research and development because new technologies have advanced their ability to create vaccines not thought possible before.
More Related Videos
Related Concept Videos
Vaccine Production
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Vaccines
Vaccinations
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...

